- Hepatic Encephalopathy market is competitive.
- Ocera has yet to show a convincing advantage over other alternatives.
- Ocera's OCR002 molecule faces a fundamental risk.
Ocera Therapeutics Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel therapeutics for patients with acute and chronic liver disease, an area of high unmet medical need.